Zobrazeno 1 - 10
of 434
pro vyhledávání: '"Winette T A, Van der Graaf"'
Autor:
Magdalena Mileva, Elisabeth G. E. de Vries, Thomas Guiot, Zéna Wimana, Anne-Leen Deleu, Carolien P. Schröder, Yolene Lefebvre, Marianne Paesmans, Sigrid Stroobants, Manon Huizing, Philippe Aftimos, Jolien Tol, Winette T. A. Van der Graaf, Wim J. G. Oyen, Danielle J. Vugts, C. Willemien Menke-van der Houven van Oordt, Adrienne H. Brouwers, Martine Piccart-Gebhart, Patrick Flamen, Géraldine Gebhart
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-10 (2024)
Abstract Efficacy of the human epidermal growth factor receptor (HER)2-targeting trastuzumab emtansine (T-DM1) in breast cancer (BC) relies on HER2 status determined by immunohistochemistry or fluorescence in-situ hybridization. Heterogeneity in HER2
Externí odkaz:
https://doaj.org/article/b8159ecb1674471b9a212c77843626e6
Autor:
Olga Husson, Silvie H. M. Janssen, Bryce B. Reeve, Samantha C. Sodergren, Christabel K. Cheung, Martin G. McCabe, John M. Salsman, Winette T. A. van der Graaf, Anne-Sophie Darlington
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Adolescents and young adults (AYAs) with cancer, defined as individuals aged 15–39 years at initial cancer diagnosis, form a unique population; they face age-specific issues as they transition to adulthood. This paper presents t
Externí odkaz:
https://doaj.org/article/0fcd4b9e3aff47ba828dfec7fdedec57
Autor:
Carla Vlooswijk, Silvie H. M. Janssen, Lonneke V. van de Poll-Franse, Rhodé Bijlsma, Suzanne E. J. Kaal, J. Martijn Kerst, Jacqueline M. Tromp, Monique E. M. M. Bos, Roy I. Lalisang, Janine Nuver, Mathilde C. M. Kouwenhoven, Winette T. A. van der Graaf, Olga Husson
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-10 (2023)
Abstract The health-related quality of life (HRQoL) among long-term Adolescent and Young Adult Cancer Survivors (AYACS) and an age- and sex-matched normative population was examined. Although the HRQoL of AYACS was worse compared to the normative pop
Externí odkaz:
https://doaj.org/article/f5f0deb22ffa4615a0e3a20bf3ffda80
Autor:
Carla Vlooswijk, Lonneke V. van de Poll-Franse, Silvie H. M. Janssen, Esther Derksen, Milou J. P. Reuvers, Rhodé Bijlsma, Suzanne E. J. Kaal, Jan Martijn Kerst, Jacqueline M. Tromp, Monique E. M. M. Bos, Tom van der Hulle, Roy I. Lalisang, Janine Nuver, Mathilde C. M. Kouwenhoven, Winette T. A. van der Graaf, Olga Husson
Publikováno v:
Current Oncology, Vol 29, Iss 8, Pp 5407-5425 (2022)
Background: Participation of Adolescents and Young Adults with cancer (AYAs: 18–39 years at time of diagnosis) in patient-reported outcome studies is warranted given the limited knowledge of (long-term) physical and psychosocial health outcomes. We
Externí odkaz:
https://doaj.org/article/97884f2644a9406ba9630ba145aa510a
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Osteosarcoma (OS) and Ewing sarcoma (ES) are the two most common types of primary bone cancer that predominantly affect the young. Despite aggressive multimodal treatment, survival has not improved significantly over the past four decades. Clinical e
Externí odkaz:
https://doaj.org/article/29fc98c8140642d48364ea08c1f8835c
Autor:
Dide den Hollander, Emma Lidington, Susanne Singer, Samantha C. Sodergren, Samer Salah, Marco Fiore, Charlotte Benson, Ingrid M. E. Desar, Vivian W. G. Burgers, Olga Husson, Winette T. A. van der Graaf
Publikováno v:
Health and Quality of Life Outcomes, Vol 20, Iss 1, Pp 1-18 (2022)
Abstract Background Uterine sarcomas are rare subtypes of primary urogenital tumours and need tailored treatment. This study aimed to examine the impact of diagnosis and treatment on health-related quality of life (HRQoL) in patients with uterine sar
Externí odkaz:
https://doaj.org/article/42c61bad7fa84ec1bcb99546181b6335
Autor:
Evelien G. E. Hurkmans, Marije J. Klumpers, Cinzia Dello Russo, Ward De Witte, Henk-Jan Guchelaar, Hans Gelderblom, Anne-Marie Cleton-Jansen, Sita H. Vermeulen, Suzanne Kaal, Winette T. A. van der Graaf, Uta Flucke, Corrie E. M. Gidding, Hendrik W. B. Schreuder, Eveline S. J. M. de Bont, Huib N. Caron, Giovanna Gattuso, Elisabetta Schiavello, Monica Terenziani, Maura Massimino, Geoff McCowage, Sumanth Nagabushan, Anuja Limaye, Victoria Rose, Daniel Catchpoole, Andrea L. Jorgensen, Christopher Barton, Lucy Delaney, Daniel B. Hawcutt, Munir Pirmohamed, Barry Pizer, Marieke J. H. Coenen, D. Maroeska W. M. te Loo
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2023)
Hearing loss (ototoxicity) is a major adverse effect of cisplatin and carboplatin chemotherapy. The aim of this study is to identify novel genetic variants that play a role in platinum-induced ototoxicity. Therefore, a genome-wide association study w
Externí odkaz:
https://doaj.org/article/a8f79afc4fc54f8c9b487d722feb88e0
Autor:
Vivian W. G. Burgers, Martin J. van den Bent, Judith A. C. Rietjens, Daniëlle C. Roos, Annemiek Dickhout, Suzanne A. Franssen, Marloes J. Noordoek, Winette T. A. van der Graaf, Olga Husson
Publikováno v:
Frontiers in Psychology, Vol 13 (2022)
IntroductionAdolescents and young adults with an uncertain or poor cancer prognosis (UPCP) are confronted with ongoing and unique age-specific challenges, which forms an enormous burden. To date, little is known about the way AYAs living with a UPCP
Externí odkaz:
https://doaj.org/article/1f6b69dd29df4460a325e99568a1f98f
Autor:
Vivian W. G. Burgers, Martin J. van den Bent, Linda Dirven, Roy I. Lalisang, Jacqueline M. Tromp, Annette Compter, Mathilde Kouwenhoven, Monique E. M. M. Bos, Adrianus de Langen, Milou J. P. Reuvers, Suzanne A. Franssen, Simone A. M. M. Frissen, Niels C. G. L. Harthoorn, Annemiek Dickhout, Marloes J. Noordhoek, Winette T. A. van der Graaf, Olga Husson
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionIncreasingly more adolescent and young adult (AYA, aged 18–39 years) patients with an uncertain and/or poor cancer prognosis (UPCP) are gaining life-years because of novel treatments or refinement of established therapies, and sometimes
Externí odkaz:
https://doaj.org/article/1ad7834fe78843e3858a8501981ddaf7
Autor:
Evelien G. E. Hurkmans, Jan B. Koenderink, Jeroen J. M. W. van den Heuvel, Yvonne M. H. Versleijen-Jonkers, Melissa H. S. Hillebrandt-Roeffen, Johanne M. Groothuismink, Hanneke I. Vos, Winette T. A. van der Graaf, Uta Flucke, Grigor Muradjan, Hendrik W. B. Schreuder, Melanie M. Hagleitner, Han G. Brunner, Hans Gelderblom, Anne-Marie Cleton-Jansen, Henk-Jan Guchelaar, Eveline S. J. M. de Bont, Daan J. Touw, G. Jan Nijhoff, Leontien C. M. Kremer, Huib Caron, Rachael Windsor, Ana Patiño-García, Anna González-Neira, Federica Saletta, Geoff McCowage, Sumanth Nagabushan, Daniel Catchpoole, D. Maroeska W. M. te Loo, Marieke J. H. Coenen
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Despite (neo) adjuvant chemotherapy with cisplatin, doxorubicin and methotrexate, some patients with primary osteosarcoma progress during first-line systemic treatment and have a poor prognosis. In this study, we investigated whether pati
Externí odkaz:
https://doaj.org/article/41ddb83527fc4a9bae06e65f39652d1c